How Europe is balancing AI-driven healthcare innovation with new regulations like the AI Act and EHDS, and what health systems need to adopt AI responsibly.
Europe’s AI Healthcare Journey: Innovation, Regulation, and Roadblocks Read More »
Lucis secured $20M Series A to expand its AI-backed preventive health platform that uses 110+ biomarkers, physician-reviewed insights, and proven clinical outcomes across Europe.
Lucis Raises $20M Series A to Scale AI-Driven Preventive Healthcare Across Europe Read More »
Europe stands at a pivotal moment for AI in health. From diagnostics to biomanufacturing, regulators are acting while data fragmentation, ethics, and system readiness remain urgent issues.
AI in European Healthcare: Opportunities and Hurdles Read More »
GE HealthCare’s HelloAI delivers 20+ hours of free, on-demand AI training for clinicians, researchers and leaders to build practical AI fluency and responsible use.
GE HealthCare Offers Free HelloAI Training to Boost Clinician AI Fluency Read More »
How AI is cutting drug discovery timelines: target identification, molecule design, toxicity prediction, and regulatory issues shaping faster therapies.
AI Accelerates Drug Discovery: Faster Paths from Lab to Patient Read More »
NHS Shared Business Services unveils a £900m AI procurement framework (2027-2035) to buy diagnostics, analytics and robotics tech, while sparking spending debate.
NHS Launches £900M AI Healthcare Framework to Drive UK Adoption Read More »
How AI is improving medical imaging for earlier, more accurate diagnoses. Learn about performance gains, patient benefits, and what comes next in clinical use.
AI in Precision Diagnostics: Medical Imaging Breakthroughs Read More »
Practical strategies for healthcare leaders to build patient trust in AI: transparency, strong data governance, clinician communication, patient-centered design, and human-AI collaboration.
Patient Trust: How to Drive AI Adoption in Healthcare Read More »
Explore how Pfizer, Tempus AI and Medtronic apply artificial intelligence across drug R&D, precision medicine and medical devices to transform care.
AI in Healthcare: How Pfizer, Tempus AI and Medtronic Are Driving Change Read More »
Mayo Clinic’s radiomics AI flags pancreatic cancer up to 3 years earlier using routine CT scans. What this means for early diagnosis, barriers to rollout, and scalable solutions.
